Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02300987 |
| Title | A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | NLD | FRA | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| USC Kenneth Norris Comprehensive Cancer Center Oncology Dept | Los Angeles | California | 90033 | United States | Details | |
| New Mexico Cancer Care Alliance | Albuquerque | New Mexico | 87106 | United States | Details | |
| Memorial Sloan Kettering Oncology Department. | New York | New York | 10017 | United States | Details | |
| Novartis Investigative Site | Villejuif Cedex | 94800 | France | Details | ||
| Novartis Investigative Site | Groningen | 9713 GZ | Netherlands | Details | ||
| Novartis Investigative Site | Hospitalet de LLobregat | Catalunya | 08907 | Spain | Details | |
| Novartis Investigative Site | Madrid | 28041 | Spain | Details |